Creon® Mode of Action

Watch how Creon®’s mode of action ensures optimal enzyme delivery.

Loading the player...

References

  1. Littlewood JM et al. Expert Opin. 2011; 10(2): 197-203.
  2. Keller J et al. Gut. 2005; 54(Suppl6): 1-28.
  3. Creon Micro Summary of Product Characteristics. November 2016.
  4. Creon 10000 Capsules Summary of Product Characteristics. January 2017.
  5. Creon 25000 Capsules Summary of Product Characteristics. January 2017.
  6. Creon 40000 Capsules Summary of Product Characteristics. February 2017.
  7. Imrie C et al. Aliment Pharmcaol Ther. 2010; 32(1): 1-25.
  8. Toouli J et al. Med J Aust. 2010; 193(8): 461-7.
  9. Fieker A et al. Clin Exp Gastroenterol. 2011; 4: 55-73.
  10. Löhr J-M et al. Eur J Gastroenterol Hepatol. 2009; 21: 1024-31.
  11. Ramesh H. Pancreatology. 2013; 13: 133-9.

You will now leave the Creon patient website and go to the Creon Track site where you can join the Creon Track patient support programme

Would you like to proceed to the Creon Track registration website?

OK
NO